Pharmacokinetic comparison of an oral diclofenac potassium liquid-filled soft gelatin capsule with a diclofenac potassium tablet

Expert Opinion on Pharmacotherapy

Volumn 11, Issue 5, 2010, Pages 701-708

  Lissy, Michael ^a   Scallion, Ralph ^b   Stiff, Dwight D ^a   Moore, Keith ^c  

^a AAIPharma Inc   (Germany)

^b Private Practice   (United States)

^c Xanodyne Pharmaceuticals Inc   (United States)

Author keywords

Diclofenac potassium; Immediate release formulation; Nonsteroidal anti inflammatory drug; ProSorb technology

Indexed keywords

DICLOFENAC POTASSIUM; GELATIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMOGRAPHY; DIZZINESS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG INDUCED HEADACHE; DRUG LABELING; DRUG RELEASE; DRUG SAFETY; FEMALE; HEMATOMA; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PHLEBITIS; RANDOMIZED CONTROLLED TRIAL; RHINITIS; TABLET FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CAPSULES; CROSS-OVER STUDIES; DICLOFENAC; FEMALE; HUMANS; MALE; MIDDLE AGED; TABLETS; TIME FACTORS; YOUNG ADULT;

EID: 77949437137     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656561003614773     Document Type: Article

References (25)

1. Label and approval history for Voltaren®. Drugs@FDA. Silver Spring, MD: FDA Center for Drug Evaluation and Research, 2008. Available from: http://www. accessdata.fda.gov/scripts/cder/drugsatfda/ [Accessed 13 August 2009]
2. Graham DJ, Campen D, Hui R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 2005;365:475-481
3. Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. Br Med J 2005;330:1366
4. Mitchell JA, Warner TD. Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol 1999;128:1121-1132
5. Breivik EK, Barkvoll P, Skovlund E. Combining diclofenac with acetaminophen or acetaminophen-codeine after oral surgery: a randomized, double-blind single-dose study. Clin Pharmacol Ther 1999;66:625-635
6. Hersh EV, Levin LM, Adamson D, et al. Dose-ranging analgesic study of Prosorb diclofenac potassium in postsurgical dental pain. Clin Ther 2004;26:1215-1227
7. Matthews RW, Scully CM, Levers BG. The efficacy of diclofenac sodium (Voltarol) with and without paracetamol in the control of post-surgical dental pain. Br Dent J 1984;157:357-359
8. Bamber MJ, Tweedie IE, Breeze C, et al. Premedication with controlled release diclofenac sodium reduces post-operative pain after minor gynaecological surgery. Eur J Anaesthesiol 1997;14:421-427
9. McEvoy A, Livingstone JI, Cahill CJ. Comparison of diclofenac sodium and morphine sulphate for postoperative analgesia after day case inguinal hernia surgery. Ann R Coll Surg Engl 1996;78:363-366
10. Hinz B, Chevts J, Renner B, et al. Bioavailability of diclofenac potassium at low doses. Br J Clin Pharmacol 2005;59:80-84
11. Lotsch J, Kettenmann B, Renner B, et al. Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: relation to pharmacodynamics in an experimental pain model. Pharm Res 2000;17:77-84
12. Macia MA, Frias J, Carcas AJ, et al. Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks. Int J Clin Pharmacol Ther 1995;33:333-339
13. Reiner V, Reiner A, Reiner G, et al. Increased absorption rate of diclofenac from fast acting formulations containing its potassium salt. Arzneimittelforschung 2001;51:885-890
14. Terhaag B, Hoffmann A, Barkworth M, et al. Bioavailability of a new effervescent tablet of diclofenac. Int J Clin Pharmacol Ther 2000;38:546-551
15. Ceppi Monti N, Gazzaniga A, Gianesello V, et al. Activity and pharmacokinetics of a new oral dosage form of soluble ibuprofen. Arzneimittelforschung 1992;42:556-559
16. Laska EM, Sunshine A, Marrero I, et al. The correlation between blood levels of ibuprofen and clinical analgesic response. Clin Pharmacol Ther 1986;40:1-7
17. Seymour RA, Hawkesford JE, Weldon M, et al. An evaluation of different ibuprofen preparations in the control of postoperative pain after third molar surgery. Br J Clin Pharmacol 1991;31:83-87
18. Zuniga JR, Phillips CL, Shugars D, et al. Analgesic safety and efficacy of diclofenac sodium softgels on postoperative third molar extraction pain. J Oral Maxillofac Surg 2004;62:806-815
19. Mitchell JA, Akarasereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993;90:11693-11697
20. Willis JV, Kendall MJ, Flinn RM, et al. The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur J Clin Pharmacol 1979;16:405-410
21. Terhaag B, Gramette T, Hrdlcka P, et al. The influcence of food on the absorption of diclofenac as a pure substance. Int J Clin Pharmacol Ther Toxicol 1991;29:418-421
22. Scallion R, Moore KA. Effects of food intake on the pharmacokinetics of diclofenac potassium soft gelatin capsules: a single-dose, randomized, two-way crossover study. Clin Ther 2009;31:2233-2241
23. Jamali F, Kunz-Dober CM. Pain-mediated altered absorption and metabolism of ibuprofen: an explanation for decreased serum enantiomer concentration after dental surgery. Br J Clin Pharmacol 1999;47:391-396
24. Zuniga JR, Phillips CL, Shugars D, et al. Analgesic safety and efficacy of diclofenac sodium softgels on postoperative third molar extraction pain. J Oral Maxillofac Surg 2004;62(7):806-815
25. Riff DS, Duckor S, Gottlieb I, et al. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days. Clin Ther 2009;31:2072-2084